Treatment of relapsed hyperthyroidism
Journal of the Korean Medical Association
;
: 248-252, 2018.
Artículo
en Coreano
| WPRIM
| ID: wpr-766499
ABSTRACT
Graves disease is the most common disease that causes hyperthyroidism. It is an autoimmune disease characterized by the overproduction of thyroid hormones due to continuous stimulation of the thyroid gland by thyroid-stimulating hormone receptor antibody. Therapeutic modalities for Graves disease include antithyroid drugs (ATDs), radioactive iodine, and thyroidectomy. ATDs are the most preferred therapeutic option by physicians in most countries except North America. However, current treatment strategies are unfortunately aimed at inhibiting thyroid hormone production or ablating the thyroid to induce permanent hypothyroidism, not at inhibiting thyroid-stimulating hormone receptor antibody. ATD therapy has a high relapse rate (more than 50%), and morbidity and mortality increase in cases of relapse. Therefore, the proper and prompt management of relapsed patients is very important.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Recurrencia
/
Enfermedades Autoinmunes
/
Antitiroideos
/
Glándula Tiroides
/
Hormonas Tiroideas
/
Tiroidectomía
/
Tirotropina
/
Enfermedad de Graves
/
Mortalidad
/
Hipertiroidismo
Tipo de estudio:
Estudio pronóstico
Límite:
Humanos
País/Región como asunto:
America del Norte
Idioma:
Coreano
Revista:
Journal of the Korean Medical Association
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS